Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL27890807

Clc1cnc2[nH]cc(I)c2c1.N

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.57
BRD4 O60885 1/20 0.46
CYP2C9 P11712 4/20 0.41
CYP3A4 P08684 4/20 0.41
CYP2C19 P33261 2/20 0.41
CHEK1 O14757 1/20 0.41
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
KIT P10721 3/20 0.38
LCK P06239 1/20 0.38
PGR P06401 1/20 0.38
CSF1R P07333 1/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
PDGFRB P09619 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1053943 0.98 JAK2 (0.58) JAK2BRD4CYP2C9CYP3A4CYP2C19
SCHEMBL15241762 0.79 BRD4 (0.49) JAK2BRD4CHEK1MAPK1KIT
SCHEMBL20408723 0.78 KIT (0.59) JAK2BRD4KITAXLCDK8
Ammonia Solution, Strong SCHEMBL27874537 0.78 DYRK1A (0.57) JAK2BRD4CHEK1MAPK1CSF1R
SCHEMBL1880862 0.76 BRD4 (0.47) BRD4MAPK1KITAXLCDK8
SCHEMBL1045946 0.76 BRD4 (0.54) JAK2BRD4CYP2C9CYP3A4CYP2C19
SCHEMBL68662 0.76 DYRK1A (0.58) JAK2BRD4CHEK1MAPK1CSF1R
SCHEMBL29928376 0.76 JAK2 (0.54) JAK2CYP2C9CYP3A4CYP2C19CYP2D6
SCHEMBL11968454 0.76 BRD4 (0.47) JAK2BRD4CHEK1MAPK1KIT
SCHEMBL12657249 0.76 JAK2 (0.54) JAK2CYP2C9CYP3A4CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102695417-A Compounds and methods for kinase modulation and indications therefor PLEXXIKON INC 2012-09-26 CN disclosed